Nyxoah S A (NYXH) Stock Price, Quote & News

Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 32 1 045 90 75

Fax: 32 1 045 90 75

Website: www.nyxoah.com

Address:

Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium

mpired Jun. 25 at 9:56 PM

$NYXH pop soon?

0 · Reply

MasterOfMyDomains Jun. 18 at 3:12 PM

$NYXH No follow through....?

0 · Reply

FinacialSuicide Jun. 18 at 12:04 AM

$NYXH Expecting a better day tomorrow! 🤞Today’s news was positive!

0 · Reply

DipBuyInvester Jun. 17 at 10:28 PM

$NYXH Looks great. Load before it takes off. https://finance.yahoo.com/healthcare/articles/nyxoah-receives-15-million-european-200500478.html

0 · Reply

DipBuyInvester Jun. 17 at 9:01 PM

$NYXH now taking off.

0 · Reply

DipBuyInvester Jun. 17 at 8:56 PM

$NYXH 🚀🚀🚀🔥🔥🔥👀👀👀🚀🚀💪💪

0 · Reply

AveraveJoeTrader Jun. 17 at 8:46 PM

$NYXH Added Twice on the dip ready to pop

0 · Reply

DipBuyInvester Jun. 17 at 8:28 PM

$NYXH 👀👀👀👀🔥🔥🔥🔥💪💪🚀🚀🚀

0 · Reply

mpired Jun. 17 at 8:22 PM

$NYXH lol

1 · Reply

DipBuyInvester Jun. 17 at 8:20 PM

$NYXH Load the boat. https://finance.yahoo.com/healthcare/articles/nyxoah-receives-15-million-european-200500478.html

0 · Reply

Information on the total number of voting rights and shares

Mon, 29 Jun 2026 16:30:00 -0400 - 5 days ago

Publication relating to transparency notifications

Tue, 23 Jun 2026 16:05:00 -0400 - 11 days ago

Nyxoah to Host Investor Day in New York on July 8, 2026

Fri, 19 Jun 2026 16:30:00 -0400 - 15 days ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 9, 2026

Wed, 17 Jun 2026 16:30:00 -0400 - 17 days ago

Publication relating to transparency notifications

Wed, 17 Jun 2026 16:05:00 -0400 - 17 days ago

Nyxoah Receives $15 Million from the European Investment Bank

2026-06-17T10:55:08.000Z - 17 days ago

Nyxoah price target lowered to $3 from $5 at Stifel

Wed, 10 Jun 2026 17:00:00 -0400 - 23 days ago

Information on the total number of voting rights and shares

Wed, 10 Jun 2026 16:30:00 -0400 - 24 days ago

$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch

Wed, 10 Jun 2026 16:05:00 -0400 - 24 days ago

Nyxoah Announces Closing of Underwritten Public Offering

2026-06-05T15:45:09.000Z - 4 weeks ago

Nyxoah S.A. trading resumes

2026-06-05T15:36:10.000Z - 4 weeks ago

Nyxoah 55.23M share Spot Secondary priced at $1.72

Fri, 05 Jun 2026 11:25:00 -0400 - 4 weeks ago

Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

2026-06-05T13:57:42.000Z - 4 weeks ago

Nyxoah S.A. trading halted, news pending

2026-06-04T20:14:55.000Z - 4 weeks ago

Nyxoah announces offering of ordinary shares, no amount given

2026-06-04T20:05:10.000Z - 4 weeks ago

Nyxoah announces plan to transition to U.S.-based CEO

Thu, 04 Jun 2026 16:02:00 -0400 - 4 weeks ago

Nyxoah Announces Proposed Offering of Ordinary Shares

Thu, 04 Jun 2026 16:01:00 -0400 - 4 weeks ago

Nyxoah Enters New Chapter of Long Term Value Creation

May 26, 2026, 7:00 AM EDT - 5 weeks ago

Nyxoah Slides: Corporate presentation

Wed, 20 May 2026 16:30:00 -0400 - 6 weeks ago

Information on the total number of voting rights and shares

Wed, 20 May 2026 16:05:00 -0400 - 6 weeks ago

Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum

May 13, 2026, 8:15 PM EDT - 7 weeks ago

Nyxoah Transcript: Bank of America Global Healthcare Conference 2026

2026-05-13T11:14:11.000Z - 7 weeks ago

Nyxoah price target lowered to $7 from $9 at Piper Sandler

Tue, 12 May 2026 21:09:14 -0400 - 7 weeks ago

Nyxoah Q1 Earnings Call Highlights

2026-05-12T22:33:58.000Z - 7 weeks ago

Nyxoah reports Q1 EPS (EUR 0.37) vs. (EUR 0.60) last year

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Nyxoah Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 7 weeks ago

Nyxoah Earnings release: Q1 2026

Tue, 12 May 2026 16:05:00 -0400 - 7 weeks ago

Nyxoah Reports First Quarter 2026 Financial and Operating Results

2026-05-12T01:45:10.000Z - 7 weeks ago

Nyxoah downgraded to Hold from Buy at Stifel

INSP

Tue, 28 Apr 2026 16:05:00 -0400 - 2 months ago

Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

2026-04-10T11:45:49.000Z - 3 months ago

Nyxoah price target lowered to $8 from $10 at Stifel

2026-03-23T10:36:07.000Z - 3 months ago

Nyxoah price target lowered to $4.62 from $5.87 at Baird

Fri, 20 Mar 2026 17:30:00 -0400 - 3 months ago

Publication relating to transparency notifications

2026-03-20T11:45:13.000Z - 3 months ago

Nyxoah price target lowered to $10 from $11 at Stifel

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Nyxoah Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Nyxoah Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Nyxoah Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 3 months ago

Nyxoah Earnings release: Q4 2025

2026-03-19T20:25:54.000Z - 3 months ago

Nyxoah reports Q4 EPS (EUR 0.59) vs. (EUR 0.46) last year

2026-03-19T20:25:46.000Z - 3 months ago

Nyxoah sees Q1 revenue up 25% vs. Q4

Thu, 19 Mar 2026 16:10:00 -0400 - 3 months ago

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 16, 2026, 8:40 AM EDT - 3 months ago

Nyxoah Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Fri, 13 Mar 2026 17:30:00 -0400 - 4 months ago

Publication relating to transparency notification

Wed, 11 Mar 2026 17:05:00 -0400 - 4 months ago

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Thu, 05 Mar 2026 16:05:00 -0500 - 4 months ago

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Wed, 25 Feb 2026 16:30:00 -0500 - 4 months ago

Information on the total number of voting rights and shares

2026-02-18T21:30:45.000Z - 4 months ago

Nyxoah signs MoU with Sheikh Shakhbout Medical City

Feb 18, 2026, 4:05 PM EST - 4 months ago

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

2026-01-29T13:35:17.000Z - 5 months ago

Nyxoah price target lowered to $11 from $12 at Stifel

2026-01-21T21:30:45.000Z - 5 months ago

Nyxoah to invest in manufacturing facility in Belgium

Jan 21, 2026, 4:05 PM EST - 5 months ago

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

Jan 15, 2026, 3:00 PM EST - 6 months ago

Nyxoah Transcript: 44th Annual J.P. Morgan Healthcare Conference

2026-01-12T21:21:43.000Z - 6 months ago

Nyxoah sees Q1 net revenue up 25% over Q1

2026-01-12T21:15:31.000Z - 6 months ago

Nyxoah reports preliminary Q4 gross revenue EUR 6.3M

Jan 12, 2026, 1:00 AM EST - 6 months ago

Publication relating to transparency notification

Dec 19, 2025, 4:05 PM EST - 7 months ago

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

2025-12-17T10:15:09.000Z - 7 months ago

Nyxoah announces commercial launch of Genio system in the Netherlands

Dec 17, 2025, 1:05 AM EST - 7 months ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

2025-12-16T10:40:30.000Z - 7 months ago

Nyxoah price target lowered to EUR 5 from EUR 7 at Baird

Dec 4, 2025, 1:30 PM EST - 7 months ago

Nyxoah Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 27, 2025, 4:05 PM EST - 7 months ago

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 26, 2025, 1:45 AM EST - 7 months ago

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Nov 13, 2025, 4:36 PM EST - 8 months ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nov 13, 2025, 4:30 PM EST - 8 months ago

Nyxoah Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Nyxoah Earnings release: Q3 2025

Nov 13, 2025, 4:12 PM EST - 8 months ago

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nov 11, 2025, 9:20 AM EST - 8 months ago

Nyxoah Transcript: Stifel 2025 Healthcare Conference

Nov 3, 2025, 4:05 PM EST - 8 months ago

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Oct 30, 2025, 5:10 PM EDT - 8 months ago

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Oct 6, 2025, 1:00 AM EDT - 9 months ago

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Sep 23, 2025, 4:10 PM EDT - 10 months ago

Nyxoah Provides an Update on Expanded Middle East Presence

Sep 15, 2025, 4:10 PM EDT - 10 months ago

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Sep 9, 2025, 5:35 PM EDT - 10 months ago

Nyxoah Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 4, 2025, 11:30 AM EDT - 10 months ago

Nyxoah Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 4:30 PM EDT - 10 months ago

Nyxoah Announces Upcoming Investor Events

Aug 18, 2025, 4:30 PM EDT - 11 months ago

Nyxoah Earnings Call Transcript: Q2 2025

Aug 18, 2025, 4:30 PM EDT - 11 months ago

Nyxoah Earnings release: Q2 2025

Aug 18, 2025, 4:10 PM EDT - 11 months ago

Nyxoah Reports Second Quarter Financial and Operating Results

Aug 11, 2025, 1:00 AM EDT - 11 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Aug 8, 2025, 4:10 PM EDT - 11 months ago

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Jul 29, 2025, 4:30 PM EDT - 1 year ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 28, 2025, 4:05 PM EDT - 1 year ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jun 13, 2025, 1:00 AM EDT - 1 year ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

May 28, 2025, 4:30 PM EDT - 1 year ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 14, 2025, 8:00 AM EDT - 1 year ago

Nyxoah Earnings Call Transcript: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Nyxoah Earnings release: Q1 2025

May 14, 2025, 1:00 AM EDT - 1 year ago

Nyxoah Reports First Quarter Financial and Operating Results

May 9, 2025, 1:00 AM EDT - 1 year ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

mpired Jun. 25 at 9:56 PM

$NYXH pop soon?

0 · Reply

MasterOfMyDomains Jun. 18 at 3:12 PM

$NYXH No follow through....?

0 · Reply

FinacialSuicide Jun. 18 at 12:04 AM

$NYXH Expecting a better day tomorrow! 🤞Today’s news was positive!

0 · Reply

DipBuyInvester Jun. 17 at 10:28 PM

$NYXH Looks great. Load before it takes off. https://finance.yahoo.com/healthcare/articles/nyxoah-receives-15-million-european-200500478.html

0 · Reply

DipBuyInvester Jun. 17 at 9:01 PM

$NYXH now taking off.

0 · Reply

DipBuyInvester Jun. 17 at 8:56 PM

$NYXH 🚀🚀🚀🔥🔥🔥👀👀👀🚀🚀💪💪

0 · Reply

AveraveJoeTrader Jun. 17 at 8:46 PM

$NYXH Added Twice on the dip ready to pop

0 · Reply

DipBuyInvester Jun. 17 at 8:28 PM

$NYXH 👀👀👀👀🔥🔥🔥🔥💪💪🚀🚀🚀

0 · Reply

mpired Jun. 17 at 8:22 PM

$NYXH lol

1 · Reply

DipBuyInvester Jun. 17 at 8:20 PM

$NYXH Load the boat. https://finance.yahoo.com/healthcare/articles/nyxoah-receives-15-million-european-200500478.html

0 · Reply

DipBuyInvester Jun. 17 at 8:18 PM

$NYXH Taking off. Catch the dip.

0 · Reply

DipBuyInvester Jun. 17 at 8:18 PM

$NYXH catch this dip.

0 · Reply

FeliciaMath Jun. 17 at 8:17 PM

$NYXH sold on spike at 2.09. made $768 (38%)

0 · Reply

premarketmaker Jun. 17 at 8:13 PM

$NYXH gap fill to $2.70 on daily

0 · Reply

premarketmaker Jun. 17 at 8:11 PM

$NYXH $2.18+ HOD/squeeze Receives $15 Million from the European Investment Bank 460K float

1 · Reply

AlertsAndNews Jun. 17 at 8:09 PM

$NYXH pop on this Nyxoah Receives $15 Million from the European Investment Bank

0 · Reply

FinanceLegacy Jun. 17 at 8:08 PM

$NYXH Nyxoah Receives $15 Million from the European Investment Bank Watching $TGE $ICCM $AMD $TSLA

0 · Reply

anachartanalyst Jun. 17 at 6:01 PM

$NYXH https://anachart.com/wp-content/uploads/2026/06/1781719288_soc-img.jpg

0 · Reply

FeliciaMath Jun. 17 at 3:31 PM

$NYXH not selling under 2.6

0 · Reply

Lilwopjob Jun. 16 at 4:15 PM

$NYXH been watching this stock without a position for a year. lots of anecdotal evidence of successfully eating into inspire market share but it has yet to really show in earnings too dramatically. anyone feel like they have a good handle on the lawsuit? that is the one piece where I am unsure of how much weight to give it. post offering announcement though, at this price, almost stupid not to open a starting position

2 · Reply

FeliciaMath Jun. 15 at 3:33 PM

bought $NYXH at 1.51

0 · Reply

Lilingpeace Jun. 15 at 12:21 PM

$NYXH Founder Robert Taub bought $17.5 million worth of shares during this past offering according to updated % ownership posted in company website

1 · Reply

Market Cap	66.67M
Revenue (ttm)	11.34M
Net Income (ttm)	-101.92M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-898.77%
Debt to Equity Ratio	0.95

Volume	110,500
Avg Vol	313,896
Day's Range	N/A - N/A
Shares Out	38.76M
Stochastic %K	72%
Beta	1.61
Analysts	Sell
Price Target	$8.50